Popular Articles

Vyvanse CII Significantly Improved ADHD Symptoms For Children 13 Hours After Administration
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, has announced that a study published online in the peer-reviewed journal Child and Adolescent Psychiatry and Mental Health found once-daily Vyvanse® (lisdexamfetamine dimesylate) CII significantly reduced the symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged 6 to 12 from the first time point measured (1.5 hours) up to the last time point assessed (13 hours) after administration. In this pediatric analog classroom study, treatment with Vyvanse was associated with significant improvement in behavior and attention in children at each time point measured, with improvement at 13 hours after administration.

Peter Lawrence's Story
The Long Path to Diagnosis
News of the day
Caucasians Are At Higher Risk Of Developing Ewing's Sarcoma Than Other Races
The largest analysis of its kind has found that Caucasians are much more likely than people in other racial/ethnic groups to develop a rare bone and soft tissue cancer called Ewing"s sarcoma. In addition, among Caucasians with this cancer, men are more likely to die than women. Published in the August 1, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that examining the gender and racial differences related to Ewing"s sarcoma could provide a better understanding of the disease and could lead to improved treatments for patients.
Nutrition

Summer Interns Arrive At Herman B Wells Center For Pediatric Research

Twenty-nine students arrived at Indiana University School of Medicine"s Herman B Wells Center for Pediatric Research to work a 10-week summer internship alongside top pediatric researchers. More than 250 applicants vied for the treasured research spots. Most of the candidates come from Indiana universities. "We welcome our new group of science majors to our labs and encourage them to make the very best of their experience here," said Weinian Shou, PhD, associate professor of pediatrics, and Wells researcher and director of the program. Each intern consults with a faculty mentor to define the research project. Students are strongly encouraged to attend a number of seminars and research-related laboratory and Wells Center meetings as part of the work experience. They are required to make a presentation at the completion of the internship and participate in a round table discussion with Wells Center faculties. Dr. Simon Rhodes, associate dean for the IUSM graduate programs, will also meet with the Wells interns to update them about IUSM graduate school programs. "I am so happy I made it," said Aiden Thompson, Loyola University master"s graduate in medical sciences. "This internship will give me a competitive edge plus such valuable knowledge and experience," he said. The program is eligible for high school seniors who are 18 years of age or older and undergraduate and graduate students. Each student receives a stipend of $2,500. Interns are responsible for their own housing and transportation. The Herman B Wells Center for Pediatric Research conducts basic science and translational research within the Department of Pediatrics at the Indiana University School of Medicine, offering exceptional opportunities for collaborations between basic scientists and physicians. The goals of the Wells Center are to increase knowledge of the causes and mechanisms of serious pediatric diseases, to develop innovative approaches to diagnosis and treatment of childhood disease, and to provide an outstanding training environment for medical and graduate students, residents, interns and fellows. Areas of pediatric research include immune disorders, blood-related and heart diseases, lung development, diabetes and cancer and growth disorders. Indiana University School of Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):